Jonathan Rosenberg

28PUBLICATIONS

226CO-AUTHORS

Medical biotechnology diagnostics (incl. biosensors)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersCancer genetics

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (28)

Sort by Publication Date:

|Jun 03, 2026

Precision Diagnostics in Prostate Cancer Treatment (PREDICT): A Phase II Multiarm Biomarker-Based Study (Alliance A032102).

|Feb 02, 2026

Neoadjuvant Nivolumab with or without Ipilimumab for Cisplatin-Ineligible Patients with Muscle-Invasive Bladder Cancer.

Brendan J Guercio, Eugene J Pietzak, Vignesh Ravichandran

|Dec 13, 2025

Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers.

Rana R McKay, Sumanta Pal, Wanling Xie

|Sep 11, 2025

End Points for the Next-Generation Bladder-Sparing Perioperative Trials for Patients With Muscle-Invasive Bladder Cancer.

Andrea Necchi, Matthew D Galsky, Nazli Dizman

|Jul 01, 2025

Relationship Among DNA Damage Response Gene Alterations, Molecular Subtypes, and Survival Outcomes in Patients With Metastatic Bladder Cancer Treated on CALGB 90601.

Gopa Iyer, Woonyoung Choi, Bin Luo

|Jun 16, 2025

Quality of Informed Consent via Telemedicine Compared With In-Person for Clinical Cancer Research.

Michal Sternschuss, Michael Lattanzi, Emily Vertosick

Pageof 5

Frequent Collaborators

12 joint publications

Hikmat Al-Ahmadie

10 joint publications

Samuel Funt

10 joint publications

Gopa Iyer

10 joint publications

Dean F Bajorin

Ashley Regazzi

David H Aggen

Min Yuen Teo

Bernard H Bochner

Thomas W Flaig

Karissa Whiting

Frequent Collaborators

12 joint publications

Hikmat Al-Ahmadie

10 joint publications

Samuel Funt

10 joint publications

Gopa Iyer

10 joint publications

Dean F Bajorin